Easterly Government Properties, Inc. (DEA) earnings date
Feb 23, 2027, before open estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 52% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 32 days, typically, give or take 12 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Mon, Oct 26, 2026 | before open | 26 | 8-K |
| Q2 FY2026 | Mon, Aug 3, 2026 | before open | 34 | 8-K |
| Q1 FY2026 | Mon, Apr 27, 2026 | before open | 27 | 8-K |
| Q4 FY2025 | Mon, Feb 23, 2026 | before open | 54 | 8-K |
| Q3 FY2025 | Mon, Oct 27, 2025 | before open | 27 | 8-K |
| Q2 FY2025 | Tue, Aug 5, 2025 | before open | 36 | 8-K |
| Q1 FY2025 | Tue, Apr 29, 2025 | before open | 29 | 8-K |
| Q4 FY2024 | Tue, Feb 25, 2025 | before open | 56 | 8-K |
What they guided beta
| Q3 FY2026 | "The dividend will be payable November 20, 2026 to shareholders of record on November 5, 2026." exhibit |
| Q3 FY2026 | "Outlook for the 12 Months Ending December 31, 2026 The Company is raising the lower end of its guidance for full-year 2026 Core FFO per share on a fully diluted basis at a range of $3.08 - $3.13." exhibit |
| Q3 FY2026 | "This guidance assumes approximately $50 million of wholly owned acquisitions and $50 - $100 million of gross development-related investment during 2026." exhibit |
| Q3 FY2026 | "Outlook for the 12 Months Ending December 31, 2027 The Company is issuing its guidance for full-year 2027 Core FFO per share on a fully diluted basis at a range of $3.09 - $3.17." exhibit |
| Q3 FY2026 | "This guidance assumes approximately $50 million of wholly owned acquisitions and $25 - $50 million of gross development-related investment during 2027." exhibit |
| Q2 FY2026 | "“Strong execution across the business, including in the capital markets, coupled with the durability of our portfolio, provides increased confidence in our earnings outlook and supports our decision to raise 2026 guidance.”" exhibit |
| Q2 FY2026 | "The dividend will be payable August 20, 2026 to shareholders of record on August 10, 2026." exhibit |
| Q2 FY2026 | "Outlook for the 12 Months Ending December 31, 2026 The Company is raising its guidance for full-year 2026 Core FFO per share on a fully diluted basis at a range of $3.07 - $3.13." exhibit |
| Q2 FY2026 | "This guidance assumes approximately $50 million of wholly owned acquisitions and $50 - $100 million of gross development-related investment during 2026." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/DEA
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/DEA
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/DEA/"><img src="https://veritasdata.dev/embed/DEA.svg" alt="DEA earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/DEA/)
Script
<script async src="https://veritasdata.dev/embed/DEA.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/DEA"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.